ArticlePharmacy practice
The attitudes of pharmacists, students and the general public on mHealth applications for medication adherence.
Article in Pharmacy practice. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 43 citations in OpenAlex.
- Evaluating Greek pharmacists' attitudes and barriers regarding medicines adherence.Journal of pharmaceutical policy and practice · 2024Article
- Article
- Evaluating usability of and satisfaction with mHealth app in rural and remote areas-Germany GIZ collaboration in Bosnia-Herzegovina to optimize type 1 diabetes care.Frontiers in digital health · 2024Article
- Article
- Exploring experiences of pharmacists and pharmacy students using mHealth apps: A qualitative study of user experience.International journal of qualitative studies on health and well-being · 2023Article
- Feasibility and user acceptability of BreezingSmart health (Amsterdam, Netherlands) · 2023Article
- NPS MedicineWise application in supporting medication adherence in chronic heart failure: an acceptability and feasibility pilot study.Frontiers in digital health · 2023Article
- Barriers to COVID-19 vaccine surveillance: the issue of under-reporting adverse events.Epidemiology and health · 2023Article
- Article
- An Innovative App (ExoDont) for Postoperative Care of Patients After Tooth Extraction: Prototype Development and Testing Study.JMIR perioperative medicine · 2021Article
- Attitudes, Beliefs, and Willingness Toward the Use of mHealth Tools for Medication Adherence in the Florida mHealth Adherence Project for People Living With HIV (FL-mAPP): Pilot Questionnaire Study.JMIR mHealth and uHealth · 2019Article
- Evaluation of a mobile health intervention to support asthma self-management and adherence in the pharmacy.International journal of clinical pharmacy · 2019Article
- Perceptions and Acceptance of mHealth in Patients With Cardiovascular Diseases: A Cross-Sectional Study.JMIR mHealth and uHealth · 2019Article
- Medication Adherence Apps: Review and Content Analysis.JMIR mHealth and uHealth · 2018Review
- Facilitators and barriers to using physical activity smartphone apps among Chinese patients with chronic diseases.BMC medical informatics and decision making · 2017Article
- Article
- EIP on AHA Ontology for adherence: Knowledge representation advanced tools.Translational medicine @ UniSaArticle
- Exploring Patient Perspectives and Willingness to Use Mobile Health Applications for Diabetes Medication Adherence: A Descriptive and Cross-Sectional Study.Journal of research in pharmacy practiceArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDuring recent years mobile technology has developed tremendously and has infiltrated the healthcare field. Mobile healthcare (mHealth) applications, or apps, may be used to support patient adherence to medication thus promoting optimal treatment outcomes and reducing medication wastage.
objectiveThis study shall consider the opinions of United Kingdom (UK) based pharmacists, pharmacy undergraduates and members of the general public towards the use of mHealth apps to promote adherence to prescribed medication regimens.
methodsOn Liverpool John Moores University (LJMU) ethical approval, the 25 item questionnaire was distributed to UK registered pharmacists within inner city Liverpool and Manchester (n=500), pharmacy undergraduates studying at LJMU (n=420) and members of the general public within Liverpool City Centre (n=400). The questions were formatted as multiple choice, Likert scales or the open answer type. The data were analysed using simple frequencies, cross tabulations and non-parametric techniques in the SPSS v22 program.
resultsThe number of completed questionnaires from the pharmacist, student and general public cohorts were 245, 333 and 400; respectively. The data indicated that the general public rely heavily upon daily routine to take medication as prescribed (54.1%) with mHealth app use being extremely low (1.5%); a similar trend was noted for the pharmacist / student cohorts. The age of the individual is an important consideration, with the younger generation likely to engage with mHealth apps and the older generation less so. Here, education and training are important. Pharmacists (82.3%) would be happy to deliver training packages to the public who would in turn happily receive such training (84%). Key barriers precluding mHealth app use include data reliability, security and technical difficulties.
conclusionAdherence apps hold great promise to support the patient and their healthcare needs. In order to increase acceptance and uptake simple, user-friendly designs must be considered and constructed. In addition, such technology requires effective promotion and end user training in order to reach its full potential. Furthermore, the regulation of mobile adherence apps will be essential in order to overcome underlying patient concerns.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.